Institut de Recherche Biomédicale des Armées
Brétigny-sur-Orge, 91223, France
NCT Number: NCT04518254
L-tyrosine is a chemical precursor of dopamine. Under specific conditions, tyrosine administration can increase brain dopamine levels and therefore several studies have explored whether tyrosine supplementation can have a beneficial effect on cognitive and behavioural performance that is dependent on dopaminergic function. However, the effects of tyrosine supplementation are mixed: some studies show positive effects while others do not. Stress leads to an increase in dopaminergic activity and turnover in the brain, resulting in a decrease in brain dopamine levels. We propose to study the contribution of tyrosine to decision making and more particularly to the processes of response selection (mediated by the prefrontal cortex and under the influence of the dopaminergic system) in stressful situations.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Brétigny-sur-Orge, 91223, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A blood sample will be collected before and after treatment administration
The participants will be administered 4 capsules of L-Tyrosine 500 mg per oral route
The participants will be administered 4 capsules of Lactose 500 mg (placebo) per oral route
The participants will perform cognitive decision-making tasks: Simon task and masking task after treatment administration
Unpleasant but not painful skin stimulations will be administered to the participants at variable intervals on the left leg during the cognitive tasks
Spielberger's State Trait Anxiety Inventory (STAI) will be filled by the participants before and after cognitive tasks
Electromyography measurements will be performed during cognitive tasks.
Electroencephalography measurements will be performed during cognitive tasks.
Time frame: At day 9 (9 days after enrollment)
Reaction Time at the cognitive tasks
Time frame: At day 9
Number of incorrect responses at the cognitive tasks
Time frame: At day 9
Error negativity on motor evoked potentials (measured by EMG)
Time frame: At day 9
Correlation coefficient between anxiety level (measured by anxiety scale) and tyrosinemia (measured in blood sample)
Time frame: At day 9
Correlation coefficient between anxiety level (measured by anxiety scale) and plasma tyrosine (measured in blood sample)
Time frame: At day 9
Correlation coefficient between cortisolaemia and melatoninaemia (measured in blood sample)
Direction Centrale du Service de Santé des Armées
Other
Acronym: TYRO-STRESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731464
Anxiety, Anxiety Disorders
Islamabad, Federal, Pakistan
View Trial DetailsNCT07255365
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02257853
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT06085105
Adverse Outcomes, Behavior
Navrongo, Ghana
View Trial Details